CAP (College of the American Pathologists), the ASCCP and WHO (World Health Organization) recommend the adjunctive use of p16 IHC in evaluation of cervical biopsies. Use of CINtec® Histology is supported by >100 peer-reviewed publications.2,3
The CINtec® Histology test is the only p16 biomarker test CE marked and U.S. 510(k) cleared for clinical use in the evaluation of cervical biopsy specimens.
In 2012, CAP and ASCCP issued the Lower Anogenital Squamous Terminology (LAST) recommendations.2 The LAST recommendations introduce unified diagnostic terminology for HPV-associated squamous lesions of the cervix and lower anogenital tract, a measure intended to improve communication among pathologists and physicians, allowing for appropriate patient management.
To learn more about these consensus findings, please download The LAST Consensus Recommendations Brochure